NPS PHARMACEUTICALS Canadian Trademark Information
Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, infectious diseases, namely, bacterial and fungal infections, cancer, immune system disorders, namely, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease and Still's disease, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, namely, depression, schizophrenia, bipolar disorder, strokes and spasticity, endocrine disorders, and bone metabolism disorders; pharmaceutical preparations for use in effecting analgesia and in pain management. Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, infectious diseases, namely, bacterial and fungal infections, cancer, immune system disorders, namely, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease and Still's disease, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, namely, depression, schizophrenia, bipolar disorder, strokes and spasticity, endocrine disorders, and bone metabolism disorders; pharmaceutical preparations for use ...
Perfect for these industries
Words that describe this mark
pharmaceutical preparations treatment prevention gastrointestinal disorders infectious diseases bacterial fungal infections cancer immune disorders rheumatoid arthritis inflammatory bowel disease crohns disease stills disease diseases involving varying levels
On Thursday, May 12, 2005, a canadian trademark registration was filed for
NPS PHARMACEUTICALS by Takeda Pharmaceuticals U.S.A., *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1257431.
The current status of this trademark filing is Registration published.
The NPS PHARMACEUTICALS
trademark is filed in the description of
Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, infectious diseases, namely, bacterial and fungal infections, cancer, immune system disorders, namely, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease and Still's disease, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, namely, depression, schizophrenia, bipolar disorder, strokes and spasticity, endocrine disorders, and bone metabolism disorders; pharmaceutical preparations for use in effecting analgesia and in pain management.
,
Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, infectious diseases, namely, bacterial and fungal infections, cancer, immune system disorders, namely, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease and Still's disease, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, namely, depression, schizophrenia, bipolar disorder, strokes and spasticity, endocrine disorders, and bone metabolism disorders; pharmaceutical preparations for use in effecting analgesia and in pain management.
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information